Abstract

Genomic imprinting refers to the mono-allelic and parent-specific expression of a subset of genes. While long recognized for their role in embryonic development, imprinted genes have recently emerged as important modulators of postnatal physiology, notably through hypothalamus-driven functions. Here, using mouse models of loss, gain and parental inversion of expression, we report that the paternally expressed Zdbf2 gene controls neonatal growth in mice, in a dose-sensitive but parent-of-origin-independent manner. We further found that Zdbf2-KO neonates failed to fully activate hypothalamic circuits that stimulate appetite, and suffered milk deprivation and diminished circulating Insulin Growth Factor 1 (IGF-1). Consequently, only half of Zdbf2-KO pups survived the first days after birth and those surviving were smaller. This study demonstrates that precise imprinted gene dosage is essential for vital physiological functions at the transition from intra- to extra-uterine life, here the adaptation to oral feeding and optimized body weight gain.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.RNA-Seq data have been deposited in GEO under accession code GSE153265

The following data sets were generated

Article and author information

Author details

  1. Juliane Glaser

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  2. Julian Iranzo

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9369-2530
  3. Maud Borensztein

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4378-5018
  4. Mattia Marinucci

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  5. Angelica Gualtieri

    Centre for Endocrinology, Queen Mary University of London, London, United Kingdom
    Competing interests
    No competing interests declared.
  6. Colin Jouhanneau

    Animal Transgenesis Platform, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  7. Aurélie Teissandier

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  8. Carles Gaston-Massuet

    Centre for Endocrinology, Queen Mary University of London, London, United Kingdom
    Competing interests
    No competing interests declared.
  9. Deborah Bourc'his

    Department of Genetics and Developmental Biology, Institut Curie, Paris, France
    For correspondence
    deborah.bourchis@curie.fr
    Competing interests
    Deborah Bourc'his, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9499-7291

Funding

FP7 Ideas: European Research Council (ERC-Cog EpiRepro)

  • Aurélie Teissandier
  • Deborah Bourc'his

Fondation Bettencourt Schueller

  • Deborah Bourc'his

Ligue Contre le Cancer

  • Juliane Glaser

BTL Charity (GN417/2238)

  • Angelica Gualtieri
  • Carles Gaston-Massuet

Action Medical Research (GN2272)

  • Angelica Gualtieri
  • Carles Gaston-Massuet

DIM Biotherapies

  • Juliane Glaser

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experimentation was approved by the Animal Care and Use Committee of the Institut Curie (agreement number: C 75-05-18) and adhered to European and National Regulation for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Directive 86/609 and 2010/63)

Copyright

© 2022, Glaser et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,491
    views
  • 252
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Juliane Glaser
  2. Julian Iranzo
  3. Maud Borensztein
  4. Mattia Marinucci
  5. Angelica Gualtieri
  6. Colin Jouhanneau
  7. Aurélie Teissandier
  8. Carles Gaston-Massuet
  9. Deborah Bourc'his
(2022)
The imprinted Zdbf2 gene finely tunes control of feeding and growth in neonates
eLife 11:e65641.
https://doi.org/10.7554/eLife.65641

Share this article

https://doi.org/10.7554/eLife.65641

Further reading

    1. Chromosomes and Gene Expression
    Carmina Lichauco, Eric J Foss ... Antonio Bedalov
    Research Article

    The association between late replication timing and low transcription rates in eukaryotic heterochromatin is well known, yet the specific mechanisms underlying this link remain uncertain. In Saccharomyces cerevisiae, the histone deacetylase Sir2 is required for both transcriptional silencing and late replication at the repetitive ribosomal DNA (rDNA) arrays. We have previously reported that in the absence of SIR2, a de-repressed RNA PolII repositions MCM replicative helicases from their loading site at the ribosomal origin, where they abut well-positioned, high-occupancy nucleosomes, to an adjacent region with lower nucleosome occupancy. By developing a method that can distinguish activation of closely spaced MCM complexes, here we show that the displaced MCMs at rDNA origins have increased firing propensity compared to the nondisplaced MCMs. Furthermore, we found that both activation of the repositioned MCMs and low occupancy of the adjacent nucleosomes critically depend on the chromatin remodeling activity of FUN30. Our study elucidates the mechanism by which Sir2 delays replication timing, and it demonstrates, for the first time, that activation of a specific replication origin in vivo relies on the nucleosome context shaped by a single chromatin remodeler.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.